Transactions
15
Insider / ARTIVION, INC.
Davis John E
Chief Commercial Officer at ARTIVION, INC.
- Company
- ARTIVION, INC.
- Ticker
- AORT
- First filing on record
- November 12, 2025
- Latest trade on record
- March 3, 2026
- SEC filings
- EDGAR ↗
Davis John E, Chief Commercial Officer at ARTIVION, INC., has disclosed 15 transactions in AORT since November 12, 2025: 0 purchases (0 open-market buys) and 9 sales, worth about $2.1M at the reported prices. The latest was filed March 4, 2026, 1 day after the trade.
Open-market buys
0
Sales
9
Avg. disclosure lag
1.9d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Davis John E made no purchases and 9 sales worth $1.7M, plus 6 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Davis John E has traded 1 stock on record; the largest by dollars is AORT.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 7 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| S | Open-market sale | 9 | 40,928 | $1.7M |
| M | Option exercise or conversion | 4 | 25,574 | $379K |
| A | Grant or award | 2 | 49,283 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 6 | 0 | 4 · $494K |
| 2025 | 9 | 0 | 5 · $1.3M |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| AORT | Sell S | March 3, 2026 | March 4, 2026 | 1d | 4,573 | $38 | $173K | Form 4 ↗ | ||
| AORT | Other A | March 2, 2026 | March 4, 2026 | 2d | 28,845 | — | — | Form 4 ↗ | ||
| AORT | Sell S | March 2, 2026 | March 3, 2026 | 1d | 2,784 | $38 | $106K | Form 4 ↗ | ||
| AORT | Other A | February 24, 2026 | February 25, 2026 | 1d | 20,438 | — | — | Form 4 ↗ | ||
| AORT | Sell S | February 24, 2026 | February 25, 2026 | 1d | 2,075 | $36 | $74K | Form 4 ↗ | ||
| AORT | Sell S | February 23, 2026 | February 25, 2026 | 2d | 3,773 | $38 | $142K | Form 4 ↗ | ||
| AORT | Sell S | December 15, 2025 | December 17, 2025 | 2d | 5,000 | $45 | $226K | Form 4 ↗ | ||
| AORT | Option / conversion M | November 17, 2025 | November 18, 2025 | 1d | 6,394 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| AORT | Option / conversion M | November 14, 2025 | November 18, 2025 | 4d | 6,393 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| AORT | Sell S | November 17, 2025 | November 18, 2025 | 1d | 6,394 | $45 | $289K | 10b5-1 plan | Form 4 ↗ | |
| AORT | Option / conversion M | November 17, 2025 | November 18, 2025 | 1d | 6,394 | $30 | $189K | 10b5-1 plan | Form 4 ↗ | |
| AORT | Sell S | November 14, 2025 | November 18, 2025 | 4d | 6,393 | $45 | $286K | 10b5-1 plan | Form 4 ↗ | |
| AORT | Option / conversion M | November 14, 2025 | November 18, 2025 | 4d | 6,393 | $30 | $189K | 10b5-1 plan | Form 4 ↗ | |
| AORT | Sell S | November 13, 2025 | November 14, 2025 | 1d | 6,563 | $46 | $301K | Form 4 ↗ | ||
| AORT | Sell S | November 10, 2025 | November 12, 2025 | 2d | 3,373 | $45 | $150K | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| March 4, 2026 | Form 4 | 0001628280-26-014892 | 2 | published | EDGAR ↗ |
| March 3, 2026 | Form 4 | 0001628280-26-013672 | 1 | published | EDGAR ↗ |
| February 25, 2026 | Form 4 | 0001628280-26-011820 | 3 | published | EDGAR ↗ |
| December 17, 2025 | Form 4 | 0001628280-25-057614 | 1 | published | EDGAR ↗ |
| November 18, 2025 | Form 4 | 0001628280-25-052820 | 6 | published | EDGAR ↗ |
| November 14, 2025 | Form 4 | 0001628280-25-052266 | 1 | published | EDGAR ↗ |
| November 12, 2025 | Form 4 | 0001628280-25-051793 | 1 | published | EDGAR ↗ |
Other insiders at ARTIVION, INC.
- Stanton Marshall S. SVP, Clinical & MD Affair 22 rows
- Holloway Jean F SVP, General Counsel 21 rows
- Mackin James P President & CEO 15 rows
- Horton Amy VP, Chief Accounting Officer 11 rows
- GREEN ANDREW M SVP, Regulatory and Quality 10 rows
- Berry Lance A EVP, COO, CFO & Treasurer 7 rows
- SEMEDO ANTHONY B. Director 3 rows
- Hoff Elizabeth A Director 2 rows
- ACKERMAN THOMAS F Director 1 row
- BEVEVINO DANIEL J Director 1 row
Everyone on file, with contracts and lobbying under the company's name: ARTIVION, INC..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Rule 10b5-1 trading plans The plan must be set up when the insider has no important non-public information.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 7 | 15 | November 12, 2025 | March 4, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.